|
 |
|
Sara E. Rosenbaum, Ph.D.
Professor of Applied Pharmaceutical
Sciences
sarar@uri.edu
Click
here for
information about Dr. Rosenbaum's lab
Education
- Ph.D., University of Liverpool, 1980
Research Interests:
Dr. Rosenbaum’s research interests
are associated with understanding the dose response relationship and factors
that effect this relationship. This area is studied through the development
and application of pharmacokinetic and pharmacodynamic models.
Research techniques used include:
the development of pharmacokinetic and pharmacodynamic models using
traditional and population methods; testing various patient demographic
characteristics as potential covariates for pharmacokinetic and/or
pharmacodynamic parameters; screening potential drug interactions;
simulations using integrated pharmacokinetic-pharmacodynamic computer models
to more clearly understand the relationship and the effect of the
perturbations of various parameters on drug response.
- Use of integrated
pharmacokinetic-pharmacodynamic models to assess the impact of altered
pharmacokinetic parameters. Detailed pharmacokinetic-pharmacodynamic
models have been created. Simulations are being carried out to assess
the importance of dose and pharmacodynamic parameters in determining the
impact of altered pharmacokinetic parameters
- Development of an integrated
pharmacokinetic-pharmacodynamic model for the dose response relationship
for warfarin. The study of the effect of variability among the drug’s
various pharmacokinetic and pharmacodynamic parameters on the response
as measured by the INR.
- Development of a Population
Pharmacokinetic Model For Zidovudine.
- Development of a Population model for
Nelfinavir and the use of population pharmacokinetics to screen for
drug-drug interactions.
Publications:
- Jackson, K., Rosenbaum, S.E., Yuen, G.,
Anderson, R., Dudley, M. and the AG 1343-511 Clinical Study Group.
"Population Pharmacokinetics of Nelfinavir in HIV Positive
Patients." Abstract 12th World AIDS Conference, Geneva, 1998
- Rosenbaum, S.E. "Effect of Variability In
Hepatic Clearance on the Bioequivalence Parameters of a Drug and its
Metabolite: Simulations Using a Pharmacostatistical Model."
Pharmaceutica Acta Helvetiae. 73:135-144. 1998.
- Generali, J., Danish, M. and Rosenbaum,
S.E. "Knowledge of and Attitudes About Adverse Drug Reaction
Reporting Among Rhode Island Pharmacists." The Annals of
Pharmacother. 29:365-369 1995
- Rosenbaum, S.E., Carter, A. and Dudley,
M.N. "Population Pharmacokinetics: Fundamentals Principles and
Applications." Drug Dev. Ind. Pharm.
21:1115-1141. 1995.
- Rosenbaum, S.E., Carter, A., Drusano,
Dudley, M.N. & VA Cooperative Study #298. "Population Pharmacokinetics
of Zidovudine in Symptomatic Patients with HIV-Infection."
Abstracts of 35th ICAAC. a10 2. 1995.
|
|

© University
of Rhode Island
Disclaimer |
|
For more
information, contact:
College of Pharmacy
Fogarty Hall, 41 Lower College Road, Kingston, RI 02881
Phone: 401-874-5842, Fax: 401-874-2181
E-mail:
pharmcol@etal.uri.edu.
The
University is an affirmative action/equal opportunity employer.
All rights reserved |